Rapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells

Rodolfo José Chaparro, Amanda R. Burton, David V. Serreze, Dario A A Vignali, Teresa P. DiLorenzo

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The method described herein provides a novel strategy for the rapid identification of CD8+ T cell epitopes relevant to type 1 diabetes in the context of the nonobese diabetic (NOD) mouse model of disease. Obtaining the large number of antigen-sensitive monospecific T cells required for conventional antigen discovery methods has historically been problematic due to (1) difficulties in culturing autoreactive CD8+ T cells from NOD mice and (2) the large time and resource investments required for the generation of transgenic NOD mice. We circumvented these problems by exploiting the rapid generation time of retrogenic (Rg) mice, relative to transgenic mice, as a novel source of sensitive monospecific CD8+ T cells, using the diabetogenic AI4 T cell receptor on NOD.SCID and NOD.Rag1-/- backgrounds as a model. Rg AI4 T cells are diabetogenic in vivo, demonstrating for the first time that Rg mice are a means for assessing the pathogenic potential of CD8+ T cell receptor specificities. In order to obtain a sufficient number of Rg CD8+ T cells for antigen screens, we optimized a method for their in vitro culture that resulted in a ∼ 500 fold expansion. We demonstrate the high sensitivity and specificity of expanded Rg AI4 T cells in the contexts of (1) specific peptide challenge, (2) islet cytotoxicity, and (3) their ability to resolve previously defined mimotope candidates from a positional scanning peptide library. Our method is the first to combine the speed of Rg technology with an optimized in vitro Rg T cell expansion protocol to enable the rapid discovery of T cell antigens.

Original languageEnglish (US)
Pages (from-to)106-115
Number of pages10
JournalJournal of Immunological Methods
Volume335
Issue number1-2
DOIs
StatePublished - Jun 1 2008

Fingerprint

Histocompatibility Antigens Class I
Type 1 Diabetes Mellitus
T-Lymphocytes
Inbred NOD Mouse
Viral Tumor Antigens
Transgenic Mice
T-Cell Antigen Receptor Specificity
Antigens
Peptide Library
T-Lymphocyte Epitopes
T-Cell Antigen Receptor
Technology
Sensitivity and Specificity
Peptides

Keywords

  • Antigen
  • CD8 T cells
  • Diabetes
  • Epitope
  • Mimotope
  • NOD
  • Peptide library
  • Retrogenic

ASJC Scopus subject areas

  • Biotechnology
  • Immunology

Cite this

Rapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells. / Chaparro, Rodolfo José; Burton, Amanda R.; Serreze, David V.; Vignali, Dario A A; DiLorenzo, Teresa P.

In: Journal of Immunological Methods, Vol. 335, No. 1-2, 01.06.2008, p. 106-115.

Research output: Contribution to journalArticle

Chaparro, Rodolfo José ; Burton, Amanda R. ; Serreze, David V. ; Vignali, Dario A A ; DiLorenzo, Teresa P. / Rapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells. In: Journal of Immunological Methods. 2008 ; Vol. 335, No. 1-2. pp. 106-115.
@article{3fe3f2be51d1426d92c60a7c5740e998,
title = "Rapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells",
abstract = "The method described herein provides a novel strategy for the rapid identification of CD8+ T cell epitopes relevant to type 1 diabetes in the context of the nonobese diabetic (NOD) mouse model of disease. Obtaining the large number of antigen-sensitive monospecific T cells required for conventional antigen discovery methods has historically been problematic due to (1) difficulties in culturing autoreactive CD8+ T cells from NOD mice and (2) the large time and resource investments required for the generation of transgenic NOD mice. We circumvented these problems by exploiting the rapid generation time of retrogenic (Rg) mice, relative to transgenic mice, as a novel source of sensitive monospecific CD8+ T cells, using the diabetogenic AI4 T cell receptor on NOD.SCID and NOD.Rag1-/- backgrounds as a model. Rg AI4 T cells are diabetogenic in vivo, demonstrating for the first time that Rg mice are a means for assessing the pathogenic potential of CD8+ T cell receptor specificities. In order to obtain a sufficient number of Rg CD8+ T cells for antigen screens, we optimized a method for their in vitro culture that resulted in a ∼ 500 fold expansion. We demonstrate the high sensitivity and specificity of expanded Rg AI4 T cells in the contexts of (1) specific peptide challenge, (2) islet cytotoxicity, and (3) their ability to resolve previously defined mimotope candidates from a positional scanning peptide library. Our method is the first to combine the speed of Rg technology with an optimized in vitro Rg T cell expansion protocol to enable the rapid discovery of T cell antigens.",
keywords = "Antigen, CD8 T cells, Diabetes, Epitope, Mimotope, NOD, Peptide library, Retrogenic",
author = "Chaparro, {Rodolfo Jos{\'e}} and Burton, {Amanda R.} and Serreze, {David V.} and Vignali, {Dario A A} and DiLorenzo, {Teresa P.}",
year = "2008",
month = "6",
day = "1",
doi = "10.1016/j.jim.2008.03.007",
language = "English (US)",
volume = "335",
pages = "106--115",
journal = "Journal of Immunological Methods",
issn = "0022-1759",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Rapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells

AU - Chaparro, Rodolfo José

AU - Burton, Amanda R.

AU - Serreze, David V.

AU - Vignali, Dario A A

AU - DiLorenzo, Teresa P.

PY - 2008/6/1

Y1 - 2008/6/1

N2 - The method described herein provides a novel strategy for the rapid identification of CD8+ T cell epitopes relevant to type 1 diabetes in the context of the nonobese diabetic (NOD) mouse model of disease. Obtaining the large number of antigen-sensitive monospecific T cells required for conventional antigen discovery methods has historically been problematic due to (1) difficulties in culturing autoreactive CD8+ T cells from NOD mice and (2) the large time and resource investments required for the generation of transgenic NOD mice. We circumvented these problems by exploiting the rapid generation time of retrogenic (Rg) mice, relative to transgenic mice, as a novel source of sensitive monospecific CD8+ T cells, using the diabetogenic AI4 T cell receptor on NOD.SCID and NOD.Rag1-/- backgrounds as a model. Rg AI4 T cells are diabetogenic in vivo, demonstrating for the first time that Rg mice are a means for assessing the pathogenic potential of CD8+ T cell receptor specificities. In order to obtain a sufficient number of Rg CD8+ T cells for antigen screens, we optimized a method for their in vitro culture that resulted in a ∼ 500 fold expansion. We demonstrate the high sensitivity and specificity of expanded Rg AI4 T cells in the contexts of (1) specific peptide challenge, (2) islet cytotoxicity, and (3) their ability to resolve previously defined mimotope candidates from a positional scanning peptide library. Our method is the first to combine the speed of Rg technology with an optimized in vitro Rg T cell expansion protocol to enable the rapid discovery of T cell antigens.

AB - The method described herein provides a novel strategy for the rapid identification of CD8+ T cell epitopes relevant to type 1 diabetes in the context of the nonobese diabetic (NOD) mouse model of disease. Obtaining the large number of antigen-sensitive monospecific T cells required for conventional antigen discovery methods has historically been problematic due to (1) difficulties in culturing autoreactive CD8+ T cells from NOD mice and (2) the large time and resource investments required for the generation of transgenic NOD mice. We circumvented these problems by exploiting the rapid generation time of retrogenic (Rg) mice, relative to transgenic mice, as a novel source of sensitive monospecific CD8+ T cells, using the diabetogenic AI4 T cell receptor on NOD.SCID and NOD.Rag1-/- backgrounds as a model. Rg AI4 T cells are diabetogenic in vivo, demonstrating for the first time that Rg mice are a means for assessing the pathogenic potential of CD8+ T cell receptor specificities. In order to obtain a sufficient number of Rg CD8+ T cells for antigen screens, we optimized a method for their in vitro culture that resulted in a ∼ 500 fold expansion. We demonstrate the high sensitivity and specificity of expanded Rg AI4 T cells in the contexts of (1) specific peptide challenge, (2) islet cytotoxicity, and (3) their ability to resolve previously defined mimotope candidates from a positional scanning peptide library. Our method is the first to combine the speed of Rg technology with an optimized in vitro Rg T cell expansion protocol to enable the rapid discovery of T cell antigens.

KW - Antigen

KW - CD8 T cells

KW - Diabetes

KW - Epitope

KW - Mimotope

KW - NOD

KW - Peptide library

KW - Retrogenic

UR - http://www.scopus.com/inward/record.url?scp=43049173734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43049173734&partnerID=8YFLogxK

U2 - 10.1016/j.jim.2008.03.007

DO - 10.1016/j.jim.2008.03.007

M3 - Article

C2 - 18439618

AN - SCOPUS:43049173734

VL - 335

SP - 106

EP - 115

JO - Journal of Immunological Methods

JF - Journal of Immunological Methods

SN - 0022-1759

IS - 1-2

ER -